402 related articles for article (PubMed ID: 36389759)
1. Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis.
Liu M; Wang H; Liu L; Cui S; Huo X; Xiao Z; Zhao Y; Wang B; Zhang G; Wang N
Front Immunol; 2022; 13():1046352. PubMed ID: 36389759
[TBL] [Abstract][Full Text] [Related]
2. Short-term risk and long-term incidence rate of infection and malignancy with IL-17 and IL-23 inhibitors in adult patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Wu S; Xu Y; Yang L; Guo L; Jiang X
Front Immunol; 2023; 14():1294416. PubMed ID: 38106423
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of investigating the mutual impact of COVID-19 and psoriasis: Focusing on COVID-19 course in psoriasis and the opinion on biologics in this setting.
Ghoreishi Amin N; Khosravi S; Atefi N; Seirafianpour F; Farhoodi S; Goodarzi A
Immun Inflamm Dis; 2023 Nov; 11(11):e1063. PubMed ID: 38018599
[TBL] [Abstract][Full Text] [Related]
4. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. A study of the efficacy and safety of plaque psoriasis treatment by TNF-α and IL-17A inhibitor biologics in patients who received the inactivated SARS-CoV-2 vaccine.
Ye S; Sun H; Xu Z; Xu B; Wu N; Wu J
Immun Inflamm Dis; 2023 Jul; 11(7):e938. PubMed ID: 37506146
[TBL] [Abstract][Full Text] [Related]
7. Specific Interleukin-1 Inhibitors, Specific Interleukin-6 Inhibitors, and GM-CSF Blockades for COVID-19 (at the Edge of Sepsis): A Systematic Review.
Wang Y; Zhu K; Dai R; Li R; Li M; Lv X; Yu Q
Front Pharmacol; 2021; 12():804250. PubMed ID: 35126138
[TBL] [Abstract][Full Text] [Related]
8. Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors.
Kridin K; Schonmann Y; Solomon A; Damiani G; Tzur Bitan D; Onn E; Weinstein O; Cohen AD
J Dermatolog Treat; 2022 Jun; 33(4):2014-2020. PubMed ID: 33759683
[TBL] [Abstract][Full Text] [Related]
9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis.
Rahmani K; Shavaleh R; Forouhi M; Disfani HF; Kamandi M; Oskooi RK; Foogerdi M; Soltani M; Rahchamani M; Mohaddespour M; Dianatinasab M
Front Public Health; 2022; 10():873596. PubMed ID: 36091533
[TBL] [Abstract][Full Text] [Related]
11. Death and invasive mechanical ventilation risk in hospitalized COVID-19 patients treated with anti-SARS-CoV-2 monoclonal antibodies and/or antiviral agents: A systematic review and network meta-analysis protocol.
Saha S
PLoS One; 2022; 17(6):e0270196. PubMed ID: 35714102
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults.
Xu K; Wang Z; Qin M; Gao Y; Luo N; Xie W; Zou Y; Wang J; Ma X
Front Immunol; 2023; 14():1113156. PubMed ID: 36936964
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
14. Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis.
Zawawi A; Naser AY; Alwafi H; Minshawi F
Front Immunol; 2021; 12():666223. PubMed ID: 34046036
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials.
Yao J; Zhang Y; Wang XZ; Zhao J; Yang ZJ; Lin YP; Sun L; Lu QY; Fan GJ
Front Public Health; 2022; 10():814669. PubMed ID: 35252093
[TBL] [Abstract][Full Text] [Related]
16. Kidney health in the COVID-19 pandemic: An umbrella review of meta-analyses and systematic reviews.
Yang L; Li J; Wei W; Yi C; Pu Y; Zhang L; Cui T; Ma L; Zhang J; Koyner J; Zhao Y; Fu P
Front Public Health; 2022; 10():963667. PubMed ID: 36172213
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update.
Tleyjeh IM; Kashour Z; Riaz M; Hassett L; Veiga VC; Kashour T
Clin Microbiol Infect; 2021 Aug; 27(8):1076-1082. PubMed ID: 33915284
[TBL] [Abstract][Full Text] [Related]
18. Effects of SARS-CoV-2 infection on hypothyroidism and subclinical hypothyroidism: a meta-analysis.
Wei J; Zhang F
Front Endocrinol (Lausanne); 2023; 14():1291774. PubMed ID: 38111709
[TBL] [Abstract][Full Text] [Related]
19. Fluvoxamine in Nonhospitalized Patients With Acute COVID-19 Infection and the Lack of Efficacy in Reducing Rates of Hospitalization, Mechanical Ventilation, and Mortality in Placebo-Controlled Trials: A Systematic Review and Meta-Analysis.
Bhuta S; Khokher W; Kesireddy N; Iftikhar S; Beran A; Mhanna M; Patel NJ; Patel M; Burmeister C; Assaly R
Am J Ther; 2022 May-Jun 01; 29(3):e298-e304. PubMed ID: 35383578
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
